US pharmaceutical giant Eli Lilly has launched anti-diabetes drug and obesity drug Mounjaro in India after receiving marketing authorisation from India's drug regulator - the Central Drugs Standard Control Organisation (CDSCO).

These are some interesting facts about Mounjaro-

1. Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection.

2. It is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).

3. Mounjaro is not for use in people with type 1 diabetes.

4. It is a single molecule designed to bind to glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists

5. Mounjaro represents a different class of medicines introduced for adults with type 2 diabetes. It works differently by directly activating GIP and GLP-1 pathways to help regulate blood sugar

6. Research has not shown if Mounjaro is safe and effective for use in children below 18 years

7. Mounjaro shouldn’t be used if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

8. Mounjaro causes a lot of side effects though and the most common ones include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain.

Northeast Now

[{"selector":"#anim-01edab77-fd4c-484a-ae24-67ac6217fec3","keyframes":{"opacity":[0,1]},"delay":0,"duration":1600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-45f5a254-655a-4c69-bd01-9aed8429f505","keyframes":{"transform":["translate3d(0px, 94.42019%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-50dcd227-6512-4ac5-9ca0-786b11ee749c","keyframes":{"opacity":[0,1]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6a085548-c277-49b8-ad56-1199bb35d219","keyframes":{"transform":["translate3d(0px, 824.90368%, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cde3411b-5eb6-41d9-8fa9-68404cd263da","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a7d78f9f-8d35-4ce6-828c-ff9431dfa21e","keyframes":{"transform":["translate3d(0px, 454.20090%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-eb14dfd1-0f1c-41c1-b00e-6aa286a1fb56","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c8f6dd04-3c74-4454-9b1a-817cf8e7d09f","keyframes":{"transform":["translate3d(0px, 295.66420%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] www.nenow.in

US pharmaceutical giant Eli Lilly has launched anti-diabetes drug and obesity drug Mounjaro in India after receiving marketing authorisation from India's drug regulator - the Central Drugs Standard Control Organisation (CDSCO).

US pharmaceutical giant Eli Lilly has launched anti-diabetes drug and obesity drug Mounjaro in India after receiving marketing authorisation from India's drug regulator - the Central Drugs Standard Control Organisation (CDSCO).

These are some interesting facts about Mounjaro-

These are some interesting facts about Mounjaro-

1. Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection.

1. Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection.

2. It is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).

2. It is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).

3. Mounjaro is not for use in people with type 1 diabetes.

3. Mounjaro is not for use in people with type 1 diabetes.

4. It is a single molecule designed to bind to glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists

4. It is a single molecule designed to bind to glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists

5. Mounjaro represents a different class of medicines introduced for adults with type 2 diabetes. It works differently by directly activating GIP and GLP-1 pathways to help regulate blood sugar

5. Mounjaro represents a different class of medicines introduced for adults with type 2 diabetes. It works differently by directly activating GIP and GLP-1 pathways to help regulate blood sugar

6. Research has not shown if Mounjaro is safe and effective for use in children below 18 years

6. Research has not shown if Mounjaro is safe and effective for use in children below 18 years

7. Mounjaro shouldn’t be used if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

7. Mounjaro shouldn’t be used if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

8. Mounjaro causes a lot of side effects though and the most common ones include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain.

8. Mounjaro causes a lot of side effects though and the most common ones include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain.

Northeast Now

Read More

Click Here